The agmdhope’s Podcast

agmdhope
  • 0.0 (0)
  • Medicine

AGMD is proud to sponsor podcasts on various digestive motility and neurogastroenterology topics. Guests inclulde medical, scientific, and nutritional experts along with patients, family members, and caregivers.

  1. May 19

    August 2025 Virtual Gastroparesis Awareness Month Program Series Featuring Chris Quesenberry. In this program, Chris discusses Advocating for Gastroparesis – A Pharmaceutical Company’s Journey.

    In this program, Chris discusses Advocating for Gastroparesis – A Pharmaceutical Company’s Journey.

    1h 3m

  2. May 17 ·  Video

    AGMD Interview Featuring Dr. Mark Pimentel - IBS Awareness - Part One 2026

    In this interview, Dr. Mark Pimentel discusses Irritable Bowel Syndrome.

    58 min

  3. Feb 25 ·  Video

    Functional Dyspepsia Featuring Dr. Bolaji Ayinde - February 2026

    AGMD is honored to have Dr. Bolaji Ayinde present Functional Dyspepsia for our Neurogastroenterology and Motility Expert Series.

    55 min

  4. 10/27/2025 ·  Video

    AGMD August 2025 Virtual Gastroparesis Awareness Month Program Series Featuring Dr. Amol Sharma

    In this program, Dr. Sharma discusses Clues and Cues from the Neurogastroenterologist: Gastroparesis and Functional Dyspepsia in EDS.   Dr. Sharma is currently the Donald O. Castell Endowed Chair in Gastroenterology at the Medical University of South Carolina (MUSC). He has a clinical and translational focus in Neurogastroenterology & Motility (NGM), particularly diabetic gastroparesis and Parkinson’s disease. He obtained his medical degree at Virginia Commonwealth University, completed internal medicine residency at Temple University Hospitals, and GI fellowship at Penn State Hershey Medical Center. After completing training, he spent 10 years on faculty at the Medical College of Georgia. Dr. Sharma’s research focus is understanding the pathophysiology of gut-brain axis in various conditions and developing innovative, non-invasive, and promising neuromodulation therapies through his insights, mentorship and collaborations, and his engineering background. He currently serves as principal investigator of a NIH-funded multi-center, randomized, sham- controlled study investigating thoracic neuromodulation for diabetic gastroparesis (RO1-DK133520) and a MPI of a Gastroenterology-Neurology Research Centers of the Consortium of Gut-Brain Communication in Parkinson disease (U01- DK140923).

    1h 5m

  5. 10/27/2025 ·  Video

    August 2025 Virtual Gastroparesis Awareness Month Program Series Featuring Chris Quesenberry

    In this program, Chris discusses Advocating for Gastroparesis – A Pharmaceutical Company’s Journey. Chris is the Chief Commercial Officer at Evoke Pharma, Inc.

    1h 3m

  6. 09/29/2022

    AGMD Conversations with Dr. Kenneth Koch - Differences Between Diabetic, Idiopathic, and Secondary Causes of Gastroparesis - December 2021

    AGMD is proud to present our series featuring Dr. Kenneth Koch.  Every other month, we will be having a conversation with Dr. Koch and focusing on various topics related to gastroparesis.   This month, Dr. Koch will discuss the Differences Between Diabetic, Idiopathic, and Secondary Causes of Gastroparesis.   There will be ample time for questions towards the end of the program.   Kenneth L. Koch, MD is Professor of Medicine, Section on Gastroenterology & Hepatology, at Wake Forest Baptist Medical Center. He has a career-long interest in understanding pathophysiological mechanisms of nausea and gastroparesis. Dr. Koch has studied extensively gastric myoelectrical activity (GMA) using serosal electrodes in animals and cutaneous electrodes in the study of normal 3 cpm GMA in humans. These studies have led to understanding gastric dysthymias are present in various nausea syndromes. In addition, a functional obstructive gastroparesis subtype was described that reflects pyloric dysfunction and response to endoscopic therapies with botulinum toxin A injection or balloon dilation. Dr. Koch is a PI in the NIH-sponsored Gastroparesis Clinical Research Consortium. Dr. Koch has written 143 peer-reviewed publications, 43 chapters, and 2 books.   Sponsored by the Association of Gastrointestinal Motility Disorders, Inc. AGMD

    1h 1m

  7. 09/24/2022

    Conversations with Dr. Kenneth Koch - Gastroparesis Awareness Special - August 2022

    AGMD is privileged to present our AGMD Conversations with Dr. Kenneth Koch, MD series. Every other month, we will be talking with Dr. Koch and focusing on various topics related to gastroparesis. August is Gastroparesis Awareness Month, and Dr. Koch answers questions about gastroparesis submitted by our audience participants. Kenneth L. Koch, MD, is a Professor of Medicine, Section on Gastroenterology & Hepatology, at Wake Forest Baptist Medical Center. He has a career-long interest in understanding pathophysiological mechanisms of nausea and gastroparesis. Dr. Koch has studied extensively gastric myoelectrical activity (GMA) using serosal electrodes in animals and cutaneous electrodes in the study of normal 3 cpm GMA in humans. These studies have led to understanding gastric dysthymias are present in various nausea syndromes. In addition, a functional obstructive gastroparesis subtype was described that reflects pyloric dysfunction and response to endoscopic therapies with botulinum toxin A injection or balloon dilation. Dr. Koch is a PI in the NIH-sponsored Gastroparesis Clinical Research Consortium. Dr. Koch has written 143 peer-reviewed publications, 43 chapters, and 2 books. This program is sponsored by the Association of Gastrointestinal Motility Disorders, Inc. | AGMD |.

    1h 5m

  8. 08/15/2022

    Conversations With Dr. Kenneth Koch - Diagnostic Tests For Gastroparesis - June 2022

    AGMD is proud to present our series featuring Dr. Kenneth Koch.  Every other month, we will be having a conversation with Dr. Koch and focusing on various topics related to gastroparesis.   This month, Dr. Koch will discuss Diagnostic Tests For Gastroparesis.   There will be ample time for questions towards the end of the program.   Kenneth L. Koch, MD is Professor of Medicine, Section on Gastroenterology & Hepatology, at Wake Forest Baptist Medical Center. He has a career-long interest in understanding pathophysiological mechanisms of nausea and gastroparesis. Dr. Koch has studied extensively gastric myoelectrical activity (GMA) using serosal electrodes in animals and cutaneous electrodes in the study of normal 3 cpm GMA in humans. These studies have led to understanding gastric dysthymias are present in various nausea syndromes. In addition, a functional obstructive gastroparesis subtype was described that reflects pyloric dysfunction and response to endoscopic therapies with botulinum toxin A injection or balloon dilation. Dr. Koch is a PI in the NIH-sponsored Gastroparesis Clinical Research Consortium. Dr. Koch has written 143 peer-reviewed publications, 43 chapters, and 2 books.

    1h 4m
See All (80)

About

AGMD is proud to sponsor podcasts on various digestive motility and neurogastroenterology topics. Guests inclulde medical, scientific, and nutritional experts along with patients, family members, and caregivers.

Information

  • Creator
    agmdhope
  • Years Active
    2K
  • Episodes
    80
  • Rating
    Clean
  • Copyright
    © Copyright AGMD - All rights reserved.
  • Show Website
    The agmdhope’s Podcast